LABCORP HOLDINGS INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
LABCORP HOLDINGS INC. (LH) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $606.80 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2026-02-24
- 2025-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $606.80M.
- 2025-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $87.50M.
- 2025-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $77.50M.
- 2024-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $932.10M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets as first filed |
|---|---|---|
| 2025-12-31 | $606.80M 10-K · filed 2026-02-24 | |
| 2025-06-30 | $87.50M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $77.50M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $932.10M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $847.00M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $334.90M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $311.00M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $663.10M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $520.60M 10-Q · filed 2024-10-29 | |
| 2022-12-31 | $1.26B 10-K · filed 2025-02-25 | |
| 2022-06-30 | $679.70M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $579.90M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $572.10M 10-K · filed 2022-02-25 | |
| 2017-07-31 | $1.62B 10-K · filed 2019-02-28 | $1.64B 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |